In this article/podcast from KevinMD.com, the author encourages readers to make some adjustments in their life to reduce the professional and personal risks associated with the stakeholders who target physicians, including corporate America, the government, patients, and the financial industry. The commentary is a response to President Biden’s multi-trillion spending plan, which targets rich corporations […]
Some researchers have found that as many as 50% of clinicians suffer from burnout, defined as a long-term stress reaction causing emotional exhaustion, depersonalization, and other symptoms that affect quality of life and physical health. According to a study published in the Journal of the American Heart Association, this specific condition is being seen in […]
The possible answer was presented during the 2020 ASH Annual Meeting, bringing into question whether current recommendations for prophylactic intravenous high-dose methotrexate — the most widely adopted method for CNS relapse prevention — are appropriate for all patients at high risk of a CNS relapse.
In this study from the Journal of Clinical Oncology, the authors attempted to characterize the cancer-associated risk factors for COVID-19 adverse outcomes. Their hypothesis was that cytotoxic chemotherapy administered within 35 days of a COVID-19 diagnosis is associated with an increased hazard ratio (HR) of severe or critical COVID-19. Were they right?
Hydroxychloroquine is an anti-malarial medication also commonly used by rheumatologists in treating RA and lupus. Can it really be used “in a few days” for COVID-19 patients as well?
Patients with advanced cancer are at a much higher risk for bad outcomes with a coronavirus diagnosis. For oncologists, this means there can be absolutely no room for complacency. What can you do to be prepared?